talarozole

Small moleculeexperimental

Talarozole was an investigational drug for the treatment of acne, psoriasis and other keratinization disorders. Development for that purpose has been discontinued. However, its effect in increasing retinoic acid is now being investigated in hand and knee osteoarthritis. — Wikipedia

Clinical trial activity

4 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Apr 1, 2004 (NCT00725348)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCC(CC)C(c1ccc(Nc2nc3ccccc3s2)cc1)n1cncn1
Mol. weight
377.52 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Racemic Mixture
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • n-(4-(2-ethyl-1-(1h-1,2,4-triazol-1-yl)butyl)phenyl)-2-benzothiazolamine
  • r115866
  • r 115866
  • r-115866
  • r-115866
  • r-115866
  • rambazole
  • rambazole
  • rambazole
  • talarozole
  • talarozole
  • talarozole
  • talarozole
  • talarozole

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00719121Phase 1Nov 1, 2006Stiefel Laboratories, Universitaire du Sart-Tilman
NCT00716144Phase 2Jun 1, 2006Stiefel Laboratories, University of Manchester
NCT00725439Phase 2Sep 1, 2004Stiefel Laboratories, University of Brussels
NCT00725348Phase 2Apr 1, 2004Stiefel Laboratories, University of Nijmegen
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Stiefel LaboratoriesFor profit4422004
Universitaire du Sart-TilmanAcademic/Hospital1012006
University of BrusselsAcademic/Hospital1012004
University of ManchesterAcademic/Hospital1012006
University of NijmegenAcademic/Hospital1012004
5 organizations
Page 1 / 1